Shares of Oklo Inc. plunged to $55.03 on May 19, extending a punishing week-long selloff that has erased roughly 25% of the stock's value since the company reported Q1 2026 earnings on May 12. The results confirmed what investors feared: net losses widened sharply to $33.1 million from $9.8 million a year ago, with an operating loss of $51.2 million, while the company still generates zero revenue. A simultaneous $1 billion stock offering deepened the pain.
• Losses Are Tripling While the Cash Register Stays Silent
Oklo burned $17.9 million in operating cash and spent $32.8 million on equipment and construction during Q1.
That cash outflow is up from $12 million a year ago — a meaningful acceleration in spending.
The company could still take years to deploy its first reactor and generate its first dollar from selling electricity. For shareholders, every quarter of widening losses without revenue makes the valuation harder to justify on fundamentals alone.
• A $1 Billion Stock Sale Spooked a Market Already on Edge
The new at-the-market equity offering puzzled some investors: with guidance pointing to full-year 2026 cash burn of only $80–$100 million and $2.5 billion already on hand, the additional issuance suggests management is pre-funding construction costs orders of magnitude larger than current spending.
That immediately raises share dilution concerns and is the biggest reason behind the stock's drop.
• The Fuel Problem Nobody Talks About Enough
Oklo's reactors run on a specialized uranium fuel called HALEU that the U.S. barely produces — the sole domestic supplier delivered about 0.9 metric tons in 2025, roughly one-fifth of what a single reactor needs.
The company faces challenges in securing fuel supply for mid-term opportunities, including planned Ohio plants. Without fuel, even a licensed reactor cannot operate.
• A July 4 Deadline Could Flip the Narrative — or Confirm the Doubts
The DOE wants advanced reactors to achieve criticality — a self-sustaining nuclear chain reaction — by July 4, 2026, and Oklo is targeting that date for its test reactor in Texas.
Success would provide the first real-world proof that Oklo's technology works outside of simulations. Failure would leave a $9.5 billion market-cap company with no revenue, no working reactor, and a stock trading 72% below its 52-week high of $193.84. Analysts still carry a consensus Buy rating with an average target of $103.38 — but the market is demanding proof, not promises.